In India, more than 250 million people are grappling with obesity, a chronic and progressive condition recognized by the World Health Organization (WHO) as a serious medical disorder. Characterized by excess body fat, obesity leads to a range of metabolic, biomechanical, and psychosocial health challenges. As the country faces a growing health crisis, pharmaceutical companies are stepping up with innovative solutions. One such solution is Mounjaro, a medication launched by Eli Lilly to combat obesity and diabetes, but the question remains: is it truly a game-changer, or just another quick fix?
Mounjaro: The New Treatment in Town
Eli Lilly’s Mounjaro (tirzepatide) has now entered the Indian market, offering an affordable alternative to managing both blood sugar levels and appetite. Available in 2.5 mg and 5 mg vials, the cost of Mounjaro in India is ₹3,500 and ₹4,375, respectively. A month’s supply of the lowest dose totals ₹14,000, which is a significant discount compared to its U.S. counterpart, where similar treatments can cost upwards of ₹43,000 per month.
The drug has already been approved by the Central Drugs Standard Control Organisation (CDSCO) and is seen as a formidable competitor to Novo Nordisk’s Ozempic. At just a fraction of the cost, Mounjaro is poised to dominate the market, especially as India becomes one of the world’s largest healthcare markets.
How Mounjaro Works
Mounjaro’s efficacy lies in its ability to target two gut hormones—GLP-1 (Glucagon-like Peptide-1) and GIP (Gastric Inhibitory Polypeptide). Both hormones play vital roles in regulating blood sugar and appetite. GLP-1 slows down stomach emptying, enhances insulin sensitivity, and suppresses hunger, while GIP improves fat metabolism and reduces insulin resistance.
As explained by Bengaluru-based nutritionist Dr. Nandita Iyer, the drug works by mimicking the natural action of these hormones, essentially signaling the body to curb excessive appetite and regulate blood sugar. In clinical trials, patients on the highest dose of Mounjaro lost an average of 21.8 kg over a period of 72 weeks, while those on lower doses still showed impressive weight loss results.
A Closer Look at Obesity and Its Treatment
Obesity is much more than a lifestyle issue; it’s a medical condition with profound biological roots. Dr. Chirag Barjatya, a renowned health influencer, emphasizes that obesity involves changes in brain circuits that control hunger and satiety, making it difficult for individuals to regulate food intake even when they are physically full. “It’s not just about willpower,” he notes. “Obesity requires medical intervention.”
Mounjaro’s impact lies in its ability to reset the brain’s hunger regulation system. By influencing the hunger hormones, the drug helps reduce cravings and “food noise,” giving individuals a chance to regain control over their eating habits and, ultimately, their weight.
Prevention Over Cure
While Mounjaro shows promising results, experts caution that prevention should remain the primary focus. Dr. Sudhir Kumar, a neurologist based in Hyderabad, advocates for a proactive approach to combating obesity and diabetes. “Lifestyle modifications, such as adopting a healthy diet, regular exercise, and sufficient sleep, can prevent obesity and type 2 diabetes in many cases,” he says.
Dr. Kumar also raises concerns about the role of multinational companies in promoting unhealthy food products, which contribute to the rise of obesity and diabetes, only for pharmaceutical companies to offer drugs as the solution. “Don’t fall into this trap,” he advises. “Prevent becoming a patient.”
The Limitations of Mounjaro
Despite its potential, Mounjaro is not a magic bullet. As with any medication, there are side effects to consider. Common issues include nausea, diarrhea, vomiting, and stomach pain. Long-term risks such as gallbladder problems and pancreatitis have also been identified.
Furthermore, experts warn that the weight loss achieved through Mounjaro may not be permanent. If the drug is discontinued, the weight may return, highlighting the need for ongoing lifestyle changes, including proper nutrition and physical activity. “Mounjaro is part of a long-term strategy, not a one-time fix,” says Dr. Iyer.
The Final Verdict
Mounjaro offers a promising solution for managing obesity and diabetes, but it is not a cure-all. While it can significantly aid in weight loss and blood sugar control, it is most effective when combined with a balanced lifestyle. The medication must only be prescribed by a doctor who can assess its appropriateness based on individual health needs.
As India faces a growing obesity and diabetes epidemic, Mounjaro could be a vital tool in addressing these conditions—but it should be viewed as part of a broader, long-term approach to health. Only time will tell if it proves to be a true lifesaver or merely another quick fix in the ongoing battle against obesity and diabetes.
Related Topics:
Do Weight Loss Injections Work For Everyone
